Not sure for a hyper growth company you can use arr growth as the proxy that didtates the benchmark for the growth in expenses. I agree, the structures need to be in place for retention as you have noted, and undoubtedly this comes at a cost
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come